About Marine Products Corporation Common Stock (MPX)
Marine Products Corporation is a leading manufacturer of recreational boats, specializing in the production of premium performance and luxury vessels. The company designs, engineers, and markets a wide range of boats, including sport boats and deck boats, under well-known brand names that are recognized for their quality and innovation. With a commitment to customer satisfaction, Marine Products focuses on delivering exceptional craftsmanship and cutting-edge technology, catering to boating enthusiasts who seek both performance and style in their on-water experiences. The company emphasizes environmental sustainability in its production processes, aiming to ensure that its products contribute positively to both the recreational boating industry and the natural environment. Read More
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Marine Products Corporation (NYSE: MPX) to MasterCraft Boat Holdings, Inc. (NasdaqGM: MCFT). Under the terms of the proposed transaction, shareholders of Marine Products will receive $2.43 in cash and 0.232 shares of MasterCraft common stock for each share of Marine Products that they own. Upon closing of the transaction, Marine Products shareholders will own 33.5% of the combined company. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.
Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Marine Products Corporation (NYSE: MPX) to MasterCraft Boat Holdings, Inc. for $2.43 per share in cash and 0.232 shares of MasterCraft common stock for each share of Marine is fair to Marine shareholders.
Combination of MasterCraft, Crest, Balise, Chaparral, and Robalo Creates a Portfolio of Leading Brands Across Four Distinct Categories, More Than Doubling Consumer Reach
Marine Products Corp (MPX) reported Q2 2025 results with revenue at $67.7M and EPS of $0.12, slightly missing estimates. Despite the miss, the stock rose 2.25% pre-market, reflecting investor optimism.
Shares of Humana Inc. (NYSE: HUM) fell sharply during Thursday’s session after the company reported fourth-quarter FY23 earnings and issued 2024 guidance.
Gainers Miromatrix Medical Inc. (NASDAQ: MIRO) shares climbed 230.7% to $3.3401 after United Therapeutics agreed to acquire the company for $3.25 per share in cash.
